Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityNo recent work listed

Hui Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7847-6960; OpenAlex author ID A5031493172. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. Syntenin Regulated by miR-216b Promotes Cancer Progression in Pancreatic Cancer. First author DOI 10.3389/fonc.2022.790788↗
  2. Aberrant expression miR-196a is associated with abnormal apoptosis, invasion, and proliferation of pancreatic cancer cells. Last author DOI 10.1097/mpa.0b013e3182962acb↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Fuqiang Zu · 1 shared paper, 2022 · strength 0.19
  2. Qingfeng Liu · 1 shared paper, 2022 · strength 0.19
  3. Xiaodong Tan · 1 shared paper, 2022 · strength 0.19
  4. Xiangyu Kong · 1 shared paper, 2013 · strength 0.04
  5. Jianqiang Liu · 1 shared paper, 2013 · strength 0.04
  6. Yiqi Du · 1 shared paper, 2013 · strength 0.04
  7. Zhaoshen Li · 1 shared paper, 2013 · strength 0.04
  8. Minghao Liu · 1 shared paper, 2013 · strength 0.04
  9. Hongyu Wu · 1 shared paper, 2013 · strength 0.04
  10. Jun Gao · 1 shared paper, 2013 · strength 0.04
  11. Yan-fang Gong · 1 shared paper, 2013 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.